Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Cardiac MRI Detects Heart Muscle Death
Uncategorized

Cardiac MRI Detects Heart Muscle Death

By medwebFeb 1, 2003
Share
Facebook Twitter Email

February 7, 2003

Cardiac MRI Detects Heart Muscle Death

CHICAGO— Researchers from Northwestern University’s Feinberg School of Medicine have demonstrated that cardiac magnetic resonance imaging (MRI) technology can detect small areas of dead heart tissue that cannot be detected by commonly used imaging techniques.

Their finding is important because these small areas of muscle cell death, known as infarcts, can be early indicators of future, more severe heart problems.

In their study involving 91 patients with known or suspected coronary artery disease, the researchers found that the traditional nuclear imaging technique, single photon emission computed tomography (SPECT), detected only 53 percent of the microinfarcts that were detected by cardiac MRI. Additionally, 13 percent of study patients with microinfarcts were shown to have none when SPECT alone was used.

The spatial resolution of cardiac MRI is 60 times great than that with SPECT, allowing cardiac MRI to detect these microinfarcts.

Results of the cardiac MRI study were reported in the February 1 issue of the journal Lancet .

Feinberg School researchers involved in the study were Francis J. Klocke, MD, professor of medicine and director of the Feinberg Cardiovascular Research Institute; Robert O. Bonow, MD, Max and Lilly Distinguished Professor of Cardiology and chief of cardiology; Thomas Holly, MD, assistant professor of medicine; Michael Elliott, MD, assistant professor of medicine; Matthias Regenfus, MD; and Michele Parker. Investigators from Duke University collaborated on the study.

While both cardiac MRI and SPECT are extremely accurate in detecting large infarcts, the Northwestern study showed that only cardiac MRI systemically detected smaller infarcts that are missed by SPECT. In other words, the smaller the infarct, the more likely that SPECT will miss it.

Heart attacks—or myocardial infarctions—occur when blood flow to an area of the heart is cut off or blocked, depriving those muscle cells of required oxygen and nutrients. When the cells die, they tend to die from the inside of the heart’s pumping chamber and progressively outward. In a large heart attack, the area of cell death can cover the entire thickness of the chamber’s wall.

However, in microinfarcts, the cell death may only travel a short distance. Since the spatial resolution of SPECT is roughly equivalent to the thickness of the heart chamber wall, it can detect only those infarcts that have traversed a good portion of the chamber wall.

During a cardiac MRI examination, which is noninvasive and radiation free, a patient is guided through the cavity of a large doughnut-shaped magnet. The magnet causes hydrogen nuclei in cells to align, and when perturbed by radio waves, they give off characteristic signals, which are then converted by computers into three-dimensional images of the heart and its structures. While MRI technology itself is 20 years old, only in the past few years has technology improved to the point where accurate images of moving tissues can be taken.

SPECT technology creates a series of “slices” of the area to be studied, with a computer assembling the slices to create an image. Patients are usually given a radioisotope, which provides information about blood flow and metabolism of tissues being studied. In the study, both groups of patients were given a contrast-enhancement agent.

To verify the findings on human subjects, the researchers performed the same tests in animal models, some without heart disease and others with known disease; then they analyzed the heart tissue after testing. The scientists performed the confirming studies in the animals to ensure that the smaller areas detected by cardiac MRI were actual areas of cell death.

Results showed that cardiac MRI and SPECT detected infarcts involving greater than 75 percent of the chamber wall. However, for infarcts involving less than 50 percent of the chamber wall, cardiac MRI detected 92 percent, while SPECT detected only 28 percent.

The investigators said that further studies are needed to establish the role of cardiac MRI in the diagnosis of heart disease.

The Northwestern cardiologists estimate that about 30 percent of patients with heart disease find that conventional methods for imaging the heart fall short in providing accurate information by which to guide treatment. They said that MRI provides crisp, three-dimensional views of cardiac anatomy with no interference from adjacent bone or air.

The image quality of cardiac MRI also surpasses that of echocardiography, another common imaging technique. Cardiac MRI can better show physicians how well the heart muscle is contracting, as well as precisely reveal areas of damaged tissue.

Duke University collaborators were Robert Judd, Raymond Kim, MD, Anja Wagner, MD, and Heiko Mahrholdt, MD, who conducted the cardiac MRI study while on the faculty of the Feinberg School.

The study was funded by grants from National Institutes of Health, the Deutsche Forschungsgemeinschaft, and the Robert Bosch Foundation.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023

Future Directions in Continuing Medical Education

Mar 14, 2023

Lieber Receives VA Rehabilitation Research and Development Award 

Mar 13, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
_5NM1245
230204_SERIO_MANDELL_Feinberg_Formal_0928
_5NM1715
_5NM0526
_5NM1026 (1)
_5NM1906
_5NM2173
230204_SERIO_MANDELL_Feinberg_Formal_0896
230204_SERIO_MANDELL_Feinberg_Formal_1113
230204_SERIO_MANDELL_Feinberg_Formal_1868
230204_SERIO_MANDELL_Feinberg_Formal_1237
230204_SERIO_MANDELL_Feinberg_Formal_1172

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.